(CLIFTON, NJ) Cantel Medical Corp. has announced that its MediVators, Inc. subsidiary has been granted permission form the FDA to market Rapicide. Rapicide is a high-level disinfectant and sterilant with label claims for a 5 minute 35 degrees Celsius contact time to achieve the high level disinfection of flexible endoscopes in automated endoscope preprocessors. The company says that Rapicide has a reuse life of 28 days which will double the 14 day restriction currently placed on many other products. For more information visit www.cantelmedical.com.
I Was There: An Infection Preventionist on the COVID-19 Pandemic
April 30th 2025Deep feelings run strong about the COVID-19 pandemic, and some beautiful art has come out of those emotions. Infection Control Today is proud to share this poem by Carmen Duke, MPH, CIC, in response to a recent article by Heather Stoltzfus, MPH, RN, CIC.
Unraveling a Candida auris Outbreak: Infection Control Challenges in a Burn ICU
March 19th 2025A Candida auris outbreak in a burn intensive care unit (BICU) in Illinois has highlighted the persistent challenges of infection control in high-risk health care settings. Despite rigorous containment efforts, this multidrug-resistant fungal pathogen continued to spread, underscoring the need for enhanced prevention strategies, environmental monitoring, and genomic surveillance.